Inhibition of IRE1α-driven pro-survival pathways is a promising therapeutic application in acute myeloid leukemia.
Sun H, Lin DC, Guo X, Kharabi Masouleh B, Gery S, Cao Q, Alkan S, Ikezoe T, Akiba C, Paquette R, Chien W, Müller-Tidow C, Jing Y, Agelopoulos K, Müschen M, Koeffler HP.
Sun H, et al. Among authors: ikezoe t.
Oncotarget. 2016 Apr 5;7(14):18736-49. doi: 10.18632/oncotarget.7702.
Oncotarget. 2016.
PMID: 26934650
Free PMC article.